The Center for Immuno-Oncology (CIO) at Dana-Farber is seeking a Scientist (New PhD grads encouraged to apply!) to contribute to the development of immunophenotyping protocols using mass and flow cytometry, along with cytokine detection methods, to comprehensively characterize human immune responses to cancer treatment.
The CIO is multi-disciplinary group that includes investigators in basic and clinical research and is dedicated to the discovery, development, and application of novel diagnostics and therapies in cancer immunology.
The Scientist will have the opportunity to contribute to high-impact publications and mentor junior Technicians. They will also have the privilege of closely partnering with departmental leadership while collaborating cross-functionally.
The Scientist should be comfortable working independently and collaboratively while exhibiting strong time & project management skills. Experience with the laboratory techniques used to study whole blood and PBMC samples such as mass and flow cytometry, ELISA/Luminex-based cytokine detection and gene expression profiling is desired. Demonstrated success in technical proficiency, scientific creativity, collaboration with others and independent thought.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.